GRI Bio announces 1-for-17 reverse stock split effective Feb 21, 2025

GRI Bio, Inc.

Reverse split at 1:17 ratio, effective 4:01 p.m. ET on Feb 21, 2025; post-split trading begins Feb 24, 2025 on Nasdaq under symbol GRI.
Outstanding shares will decrease from ~8.93 million to ~525,492; authorized share count unchanged.
Reverse split is intended to regain compliance with Nasdaq minimum bid price requirement.
Proportional adjustments will be made to exercise prices and shares for stock options, warrants, and convertible securities.
No fractional shares issued; cash payment in lieu based on closing price on Feb 21, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.